Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
Gholamreza Bidkhori, Rui Benfeitas, Martina Klevstig, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 50
Open Access | Times Cited: 182

Showing 26-50 of 182 citing articles:

Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
Yagang Song, Shuo Tian, Zhanzhan Li, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 59-76
Open Access | Times Cited: 1
Machine learning and molecular subtyping reveal the impact of diverse patterns of cell death on the prognosis and treatment of hepatocellular carcinoma
Xinyue Yan, Meng Wang, L. Min Ji, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108360-108360
Closed Access | Times Cited: 1
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
Haoqiang Yang, Jinghui Li, Yuanjie Niu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
A census of pathway maps in cancer systems biology
Brent M. Kuenzi, Trey Ideker
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 233-246
Open Access | Times Cited: 66
Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
Bindu D. Paul, Solomon H. Snyder
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 63
Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer
Rosario Avolio, Danilo Swann Matassa, Daniela Criscuolo, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 135-135
Open Access | Times Cited: 61
PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
Tian‐En Li, Shun Wang, Xiaotian Shen, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 61
Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
Bo Hu, Xiaobo Yang, Xinting Sang
Cancer Medicine (2020) Vol. 9, Iss. 20, pp. 7646-7662
Open Access | Times Cited: 56
Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite‐Protein Interaction Network
Di Chen, Yiran Zhang, Wen Wang, et al.
Advanced Science (2021) Vol. 8, Iss. 17
Open Access | Times Cited: 53
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma
Jiaqi Sun, Jun Ding, Qingsong Shen, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 627-642
Closed Access | Times Cited: 30
PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
Francisco Aguayo, Francisco Perez-Dominguez, Julio Osorio, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 22
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
Pengyue Liu, Kong Lingyu, Ying Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Lipid Metabolism as a Potential Target of Liver Cancer
Kangze Wu, Feizhuan Lin
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 327-346
Open Access | Times Cited: 6
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Samrat Chakraborty, Zewdu Yilma, Somdyuti Chakraborty, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 20, pp. 34-49
Open Access | Times Cited: 50
Dandelion polysaccharides exert anticancer effect on Hepatocellular carcinoma by inhibiting PI3K/AKT/mTOR pathway and enhancing immune response
Feng Ren, Jian Li, Xiang Yuan, et al.
Journal of Functional Foods (2019) Vol. 55, pp. 263-274
Closed Access | Times Cited: 44
Down‐regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle‐related genes
Yu Chang, Lehe Yang, Mengsi Cai, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1568-1577
Open Access | Times Cited: 43
HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues
Jiao Gong, Rong Li, Yaqiong Chen, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 41
The mechanisms of renin–angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures
Haifeng Zhang, Xiang Gao, Xuan Wang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111868-111868
Open Access | Times Cited: 36
Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction
Muhammad Arif, Martina Klevstig, Rui Benfeitas, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 34
Single-cell analysis reveals the intra-tumor heterogeneity and identifies MLXIPL as a biomarker in the cellular trajectory of hepatocellular carcinoma
Xiao Dong, Fan Wang, Chuan Liu, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism
Mengfang Liu, Na Liu, Jinlei Wang, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2896-2896
Open Access | Times Cited: 26
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
Kwang‐Hoon Chun
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1380-1380
Open Access | Times Cited: 25
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
Xiangyu Li, Ko Eun Shong, Woonghee Kim, et al.
EBioMedicine (2022) Vol. 78, pp. 103963-103963
Open Access | Times Cited: 23
MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 16
Metabolic Connectome and Its Role in the Prediction, Diagnosis, and Treatment of Complex Diseases
Weiyu Meng, Hongxin Pan, Yuyang Sha, et al.
Metabolites (2024) Vol. 14, Iss. 2, pp. 93-93
Open Access | Times Cited: 5

Scroll to top